首页 | 本学科首页   官方微博 | 高级检索  
检索        

抑制miR-33表达对急性呼吸窘迫综合征大鼠肺纤维化的影响及机制研究
引用本文:龙光文,张谦,杨秀林,吉春玲,董裕康.抑制miR-33表达对急性呼吸窘迫综合征大鼠肺纤维化的影响及机制研究[J].天津医药,2022,50(9):921-926.
作者姓名:龙光文  张谦  杨秀林  吉春玲  董裕康
作者单位:贵州省人民医院急诊内科(邮编550002)
基金项目:贵州省科技计划项目(黔科合基础[2017]1101)
摘    要:目的 探讨抑制miR-33表达对急性呼吸窘迫综合征(ARDS)大鼠肺纤维化的影响及其机制。方法 将60只SD大鼠按随机数字表法分成假手术组(Sham组)、ARDS模型组(Model组)、antagomir阴性对照组(antagomir-NC组)和miR-33 antagomir组(antagomir组),每组15只。除Sham组外,其他各组大鼠均通过颈部气管滴注脂多糖(LPS)建立ARDS模型。造模成功后给予miR-33 antagomir或antagomir-NC尾静脉注射。测定动脉血氧分压p(O2)]及氧合指数(OI);HE和Masson染色观察肺组织病理学变化;碱性水解法检测肺组织中羟脯氨酸(Hyp)含量;酶联免疫吸附试验(ELISA)检测肺泡灌洗液中炎性因子白细胞介素(IL)-1β、IL-6和肿瘤坏死因子(TNF)-α水平;实时荧光定量PCR检测肺组织中miR-33表达水平及转化生长因子β1(TGF-β1)、胶原蛋白(Collagen)Ⅰ和CollagenⅢmRNA表达水平;Western blot检测肺组织中TGF-β1、Smad2、p-Smad2、S...

关 键 词:转化生长因子β  Smad蛋白质类  肺纤维化  呼吸窘迫综合征  成人  miR-33
收稿时间:2022-01-06
修稿时间:2022-02-22

The effect and mechanism of inhibiting miR-33 expression on pulmonary fibrosis in rats with acute respiratory distress syndrome
LONG Guangwen,ZHANG Qian,YANG Xiulin,JI Chunling,DONG Yukang.The effect and mechanism of inhibiting miR-33 expression on pulmonary fibrosis in rats with acute respiratory distress syndrome[J].Tianjin Medical Journal,2022,50(9):921-926.
Authors:LONG Guangwen  ZHANG Qian  YANG Xiulin  JI Chunling  DONG Yukang
Institution:Department of Emergency Medicine, Guizhou Provincial People's Hospital, Guiyang 550002, China
Abstract:Objective To investigate the effect and mechanism of inhibiting miR-33 expression on pulmonary fibrosis in rats with acute respiratory distress syndrome (ARDS). Methods A total of 60 SD rats were divided into the Sham group, the ARDS model group (Model group), the antagomir negative control group (antagomir-NC group) and the miR-33 antagomir group (antagomir group) according to random number table method, with 15 rats in each group. Except for the Sham group, ARDS model was established by endotracheal drop of lipopolysaccharide (LPS) in other groups. After the model was successfully established, miR-33 antagomir or antagomir-NC were injected through tail vein. Arterial partial pressure of oxygen p(O2) ] and oxygenation index (OI) were measured. HE staining and Masson staining were used to observe the histopathological changes and the degree of pulmonary fibrosis of lung. The content of hydroxyproline (Hyp) in lung tissue was detected by alkaline hydrolysis method. The levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) in alveolar lavage fluid were detected by ELISA. The mRNA expression levels of miR-33 and TGF-β1, Collagen Ⅰ and Collagen Ⅲ in lung tissues were detected by qPCR. The protein expression levels of TGF-β1, Smad2, p-Smad2, Smad3, p-Smad3 and α-smooth muscle actin (α-SMA) were detected by Western blot assay. Results Compared with the Sham group, the level of p(O2) and OI were significantly decreased in the Model group (P<0.05). Lung tissue was severely damaged and there were obvious collagen fiber deposition. The Hyp content in lung tissue and levels of IL-1β, IL-6 and TNF-α in alveolar lavage fluid were significantly increased in the Model group (P<0.05). The expression levels of miR-33, the mRNA expression levels of TGF-β1, Collagen Ⅰ and Collagen Ⅲ and the protein expression levels of TGF-β1, p-Smad2/Smad2, p-Smad3/Smad3 and α-SMA in lung tissue were significantly increased (P<0.05). Compared with the Model group and the antagomir-NC group, the levels of p(O2) and OI were significantly increased in the antagomir group (P<0.05), lung tissue damage was significantly improved, and collagen fiber deposition was significantly decreased. The Hyp content in lung tissue and levels of IL-1β, IL-6 and TNF-α in alveolar lavage fluid were significantly decreased (P<0.05). The expression levels of miR-33, the mRNA expression levels of TGF-β1, Collagen Ⅰ, Collagen Ⅲ and the protein expression levels of TGF-β1, p-Smad2/Smad2, p-Smad3/Smad3 and α-SMA were significantly decreased (P<0.05). Conclusion The inhibition of miR-33 expression may improve pulmonary fibrosis in ARDS rats by inhibiting TGF-β1/Smad signaling pathway.
Keywords:transforming growth factor beta  Smad proteins  pulmonary fibrosis  respiratory distress syndrome  adult  miR-33  
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号